• 폴리머
• /
• 제35권5호
• /
• pp.424-430
• /
• 2011

Biodegradable poly[(glycine ethyl ester)-(phenylalanine ethyl ester) phosphazene](PGPP) microparticles were fabricated by electrohydrodynamic atomization to apply drug release test. Atomization parameters such as applied voltage, polymer concentration, and molecular weight were investigated to inspect their effects on the size and morphology of microparticles. The average diameter of PGPP microparticles decreased as increasing applied voltage and solution flow rate. Dichloromethane/dioxane mixture shows better results for the preparation of microparticles than single solvent owing to the different PGPP solubility in solvent. Blending PGPP polymers with proper molecular weights not only favored the production of spherical PGPP microparticles via electrohydrodynamic atomization, but also provided a way to adjust drug (rifampicin) release behavior. Drug-loaded biodegradable polyphosphazene microspheres can be fabricated via electrohydrodynamic atomization, which has potential use in biomedical applications.

• KSBB Journal
• /
• 제26권1호
• /
• pp.69-77
• /
• 2011

In this study, poly (L-lactic acid) (PLLA) microparticles containing gemcitabine hydrochloride were prepared by a supercritical fluid process, called aerosol solvent extraction system (ASES), utilizing supercritical carbon dioxide as antisolvent. The influence of process parameters such as temperature, pressure, $CO_2$ and solution flow rate, solution concentration, and feed ratio of drug to polymer on the morphology and characteristics of the microparticles was studied in detail. The gemcitabine-loaded microparticles exhibited a spherical shape with a smooth surface. The entrapment efficiency of gemcitabine increased with increasing temperature, solution concentration and $CO_2$ flow rate and with decreasing drug/polymer feed ratio. The maximum drug loading obtained from the ASES process was found to be about 11%. The ASES-processed PLLA microparticles containing gemcitabine showed a relatively high initial burst due to the presence of surface pores on the microparticles and the poor affinity between drug and polymer.

• KSBB Journal
• /
• 제26권4호
• /
• pp.333-340
• /
• 2011

In this study, gemcitabine-loaded methoxy poly(ethylene glycol)-b-poly(L-lactide) (MPEG-PLLA) microparticles with different PEG block lengths were prepared by a W/O/W double emulsion technique. The present study focuses on the investigation of the influence of various preparative parameters such as the ratio of internal water phase and oil phase, polymer concentration, solvent composition of organic phase and salt concentration of external water phase on the morphology and encapsulation efficiency of the microparticles. The microparticles fabricated at high volume ratios of internal water phase to oil phase and at high polymer concentrations showed a relatively high encapsulation efficiency and low porosity. When a dichloromethane/ethyl acetate mixture was used as solvent, both the encapsulation efficiency and drug loading of the microparticles decreased as the level of ethyl acetate increased. The addition of a salt (NaCl) to the external water phase significantly improved the encapsulation efficiency up to 40%, and the microparticles became more spherical with their size and porosity decreased.

• Macromolecular Research
• /
• 제17권12호
• /
• pp.1010-1014
• /
• 2009

Monodispersed microparticles with a poly(D,L-lactide-co-glycolide) (PLGA) core and a poly(ethyl 2-cyanoacrylate) (PE2CA) shell were prepared by Shirasu porous glass (SPG) membrane emulsification to reduce the initial burst release of doxorubicin (DOX). Solution mixtures with different weight ratios of PLGA polymer and E2CA monomer were permeated under pressure through an SPG membrane with $1.9\;{\mu}m$ pore size into a continuous water phase with sodium lauryl sulfate as a surfactant. Core-shell structured microparticles were formed by the mechanism of anionic interfacial polymerization of E2CA and precipitation of both polymers. The average diameter of the resulting microparticles with various PLGA:E2CA ratios ranged from 1.42 to $2.73\;{\mu}m$. The morphology and core-shell structure of the microparticles were observed by scanning electron microscopy (SEM) and transmission electron microscopy (TEM). The DOX release profiles revealed that the microparticles with an equivalent PLGA:E2CA weight ratio of 1:1 exhibited the optimal condition to reduce the initial burst of DOX. The initial release rate of DOX was dependent on the PLGA:E2CA ratio, and was minimized at a 1:1 ratio.

• 폴리머
• /
• 제38권1호
• /
• pp.98-102
• /
• 2014

실크 피브로인은 뛰어난 생체적합성 및 생분해성으로 인해 의료용 천연고분자소재로 각광받고 있으며 다양한 형태로 제조되어 이용되고 있다. 전기분사법은 고분자 용액에 고전압을 적용하여 미세입자를 제조하는 방법으로 진행과정이 간단하고 첨가제를 필요로 하지 않는다는 장점을 지닌다. 본 연구에서는 실크 피브로인 다공성 미세입자를 제조하기 위하여 폴리(에틸렌 글리콜)(PEG)을 첨가한 후 전기분사를 실시하였다. PEG를 첨가함으로써 분사원액의 전도도는 감소하였고 점도는 증가하였다. 제조된 미세입자의 크기는 PEG 첨가에 따라 감소하였는데 이는 분사용액의 전도도 및 점도보다는 피브로인과 PEG간의 상분리에 의한 효과인 것으로 보인다. 제조된 실크 피브로인 미세입자를 물에 침지한 결과 PEG가 제거되었으며 최종적으로 실크 피브로인 다공성 입자를 제조할 수 있었다. 제조된 다공성 실크 피브로인 미세입자는 약물전달체 및 조직공학용 세포전달체로 이용가능성이 높을 것으로 기대된다.

• Bulletin of the Korean Chemical Society
• /
• 제32권3호
• /
• pp.867-872
• /
• 2011

For the prolonged delivery and sustained release rates of low molecular weight drugs, poly(lactic-co-glycolic acid) (PLGA) microparticles containing the drug SKL-2020 have been investigated. On increasing polyvinyl alcohol (PVA) concentration (from 0.2% to 5%), the size of microparticles decreased (from $48.02{\mu}m$ to $10.63{\mu}m$) and more uniform size distribution was noticeable due to the powerful emulsifying ability of PVA. A higher drug loading (from 5% to 20%) caused a larger concentration gradient between 2 phases at the polymer precipitation step; this resulted in decreased encapsulation efficiency (from 34.19% to 25.67%) and a greater initial burst (from 61.71% to 70.05%). SKL-2020-loaded PLGA microparticles prepared with different fabrication conditions exhibited unique release patterns of SKL-2020. High PVA concentration and high drug loading led to an initial burst effect by rapid drug diffusion through the polymer matrix. Since PLGA microparticles enabled the slow release of SKL-2020 over 1 week in vitro and in vivo, more convenient and comfortable treatment could be facilitated with less frequent administration. It is feasible to design a release profile by mixing microparticles that were prepared with different fabrication conditions. By this method, the initial burst could be repressed properly and drug release rate could decrease.

• Bulletin of the Korean Chemical Society
• /
• 제35권6호
• /
• pp.1784-1788
• /
• 2014

The present study suggests a novel method to produce raspberry-like microparticles containing diverse functional materials inside. The raspberry-like microparticles were produced from a random assembly of uniformly-sized poly(methyl methacrylate) (PMMA) nanoparticles via electrospraying. The solution containing the PMMA nanoparticles were supplied through the inner nozzle and compressed air was emitted through the outer nozzle. The air supply helped fast evaporation of acetone, so it enabled copious amount of microparticles as dry powder. The microparticles were highly porous both on the surface and interiors, hence various materials with a function of UV-blocking ($TiO_2$ nanoparticles and methoxyphenyl triazine) or anti-aging (ethyl(4-(2,3-dihydro-1H-indene-5-carboxyamido) benzoate)) were loaded in large amount (17 wt % versus PMMA). The surface and interior structures of the microparticles were dependent on the characteristics of functional materials. The results clearly suggest that the process to prepare the raspberry-like microparticles can be an excellent approach to generate functional microstructures.

• 한국생물공학회:학술대회논문집
• /
• 한국생물공학회 2000년도 춘계학술발표대회
• /
• pp.541-545
• /
• 2000

For the sustained release formulation of recombinant human growth hormone (rhGH), dissociable rhGH aggregates were microencapsulated within poly(D,L-lactic-co-glycolic acid) [PLGA] microparticles. rhGH aggregates with 2 - 3 m Particle diameter were first produced by adding a small volume of aqueous rhGH solution into a partially water miscible organic solvent phase(ethyl acetate) containing PLGA. These rhGH aggregates were then microencapsulated within PLGA polymer phase by extracting ethyl acetate into an aqueous phase pre-saturated with ethyl acetate. The resultant microparticles were 2 - 3 m in diameter similar to the size of rhGH aggregates, suggesting that PLGA polymer was coated around the protein aggregates. Release profiles of rhGH from these microparticles were greatly affected by changing the volume of the incubation medium. The release rhGH species consisted of mostly monomeric form with having a correct conformation. This study reveals that sustained rhGH release could be achieved by microencapsulating reversibly dissociable protein aggregates within biodegradable polymers.

• 폴리머
• /
• 제26권1호
• /
• pp.128-138
• /
• 2002

종양부위 또는 종양을 수술로 제거한 부위에 직접 이식하여 항암제를 투여함으로써 종양 또는 종양재발을 억제하는 악성뇌종양치료에 이용하기 위한 국소서방성 항암제제로서 항암제 1,3-bis(2-chloroethyl)-1-nitrosourea (BCNU, Carmustine)가 함유된 poly(D,L-lactide-co-glycolide) (PLGA, 락타이드와 글리콜라이드 몰비 75 : 25) 미분말을 제조하여 웨이퍼로 성형하였다. BCNU가 함유된 PLGA 미분말은 분사건조법에 의해 제조하였으며 주사전자현미경으로 관찰한 결과 제조된 미분말은 미립구의 형태를 나타내었다. XRD와 DSC를 통하여 PLGA에 포접된 BCNU의 결정성이 현저히 감소하였음을 확인하였다. 생체외 방출시험조건에서 BCNU의 방출경향은 PLGA의 분자량 및 농도, BCNU의 함량 등에 의존하였으며 초기 burst effect 이후 거의 0차 방출의 경향으로 8주 이상 지속적인 방출경향을 나타내었다. 방출시험기간 동안 웨이퍼의 형태변화를 관찰하고 방출시험액의 pH 변화를 측정함으로써 BCNU의 함량이 증가할수록 PLGA의 수화와 분해가 촉진됨을 확인하였다.

• 폴리머
• /
• 제32권5호
• /
• pp.421-426
• /
• 2008

pH감응형 P(MAA-co-EGMA) 수화젤을 분산 광중합을 이용하여 마이크로 크기의 미세입자로 합성하고 화장품 제형으로서의 응용 가능성을 평가하기 위하여 모델 탑재물질인 Rh-B와 화장품 분야에서 기능성 물질로 사용되는 ascorbic acid, adenosine, EGCG, arbutin을 이용하여 탑재 및 방출 거동을 조사하였다. Rh-B 탑재의 경우, pH 6.5인 수용액에서 이온화에 의한 P(MAA-co-EGMA) 수화젤의 음전하와 Rh-B의 양전하 사이의 정전기적 인력으로 인하여 가장 높은 탑재효율을 나타내었다. 그러나 화장품 기능성 물질들의 경우, pH 6.5 수용액에서 이온화된 P(MAA-co-EGMA) 수화젤의 음전하와 기능성 물질들이 나타내는 음전하 사이의 정전기적 반발력 때문에 상대적으로 낮은 탑재효율을 나타내었다. Rh-B를 사용한 방출실험 결과, p(MAA-co-EGMA) 수화젤 미세입자는 높은 pH에서는 다량의 Rh-B를 그리고 낮은 pH에서는 소량의 Rh-B를 방출하는 pH 감응성 방출거동을 나타내었다.